AG˹ٷ

STOCK TITAN

[Form 4] Danaher Corporation Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Teri List, a director of Danaher Corporation (DHR), reported a sale of 2,778 shares of Danaher common stock on 08/22/2025 at a reported price of $211.058 per share. After the sale, the reporting person beneficially owned 20,750.672 shares, held directly. The Form 4 was signed by an attorney-in-fact on 08/25/2025.

Teri List, membro del consiglio di amministrazione di Danaher Corporation (DHR), ha dichiarato la vendita di 2.778 azioni ordinarie Danaher in data 08/22/2025 al prezzo riportato di $211.058 per azione. Dopo l'operazione la persona segnalante deteneva direttamente la proprietà beneficiaria di 20.750,672 azioni. Il modulo Form 4 è stato firmato per procura da un avvocato il 08/25/2025.

Teri List, directora de Danaher Corporation (DHR), notificó la venta de 2.778 acciones ordinarias de Danaher el 08/22/2025 a un precio informado de $211.058 por acción. Tras la venta, la persona informante poseía de forma indirecta y directamente 20.750,672 acciones. El Formulario 4 fue firmado mediante poder por un apoderado el 08/25/2025.

다나� 코퍼레이�(DHR) 이사� 테리 리스�(Teri List)� 2025-08-22� 다나� 보통� 2,778주를 주당 $211.058� 신고가� 매각했다� 보고했습니다. 매각 � 해당 보고인은 직접적으� � 20,750.672주를 사실� 보유하고 있었습니�. Form 4� 2025-08-25� 위임� 받은 대리인(변호사)� 서명했습니다.

Teri List, administratrice de Danaher Corporation (DHR), a déclaré la vente de 2 778 actions ordinaires Danaher le 08/22/2025 au prix indiqué de $211.058 par action. Après la cession, la personne déclarante détenait directement 20 750,672 actions à titre bénéficiaire. Le formulaire Form 4 a été signé par un mandataire muni d'une procuration le 08/25/2025.

Teri List, Direktorin der Danaher Corporation (DHR), meldete am 08/22/2025 den Verkauf von 2.778 Stammaktien von Danaher zu einem gemeldeten Kurs von $211.058 je Aktie. Nach dem Verkauf besaß die meldepflichtige Person unmittelbar wirtschaftlich 20.750,672 Aktien. Das Formblatt 4 wurde am 08/25/2025 von einem Bevollmächtigten unterschrieben.

Positive
  • Timely compliance with Section 16 reporting requirements: Form 4 filed and signed.
  • Clear disclosure of transaction details including date, price, and post-transaction holdings.
Negative
  • No disclosure on whether the sale was executed under a Rule 10b5-1 trading plan.
  • Lack of context about the reason for the sale limits investor interpretation of intent.

Insights

TL;DR Routine insider sale by a company director; no additional context provided to suggest material impact.

The filing documents a straightforward open-market disposition of 2,778 shares at $211.058, leaving a direct beneficial ownership of 20,750.672 shares. This Form 4 contains no indication of accelerated program sales, option exercises, or derivative transactions. As presented, the transaction appears to be a routine disclosure required under Section 16 and does not, by itself, provide information on company performance or strategy.

TL;DR A director-reported sale was disclosed; filing lacks any statement that it was part of a Rule 10b5-1 plan.

The report marks the sale as a standard Section 16 disclosure. The form does not check the box indicating a 10b5-1 plan or provide remarks explaining the sale's purpose. From a governance perspective, transparent reporting is satisfied, but the absence of plan disclosure means investors cannot determine whether the sale was pre-planned or discretionary.

Teri List, membro del consiglio di amministrazione di Danaher Corporation (DHR), ha dichiarato la vendita di 2.778 azioni ordinarie Danaher in data 08/22/2025 al prezzo riportato di $211.058 per azione. Dopo l'operazione la persona segnalante deteneva direttamente la proprietà beneficiaria di 20.750,672 azioni. Il modulo Form 4 è stato firmato per procura da un avvocato il 08/25/2025.

Teri List, directora de Danaher Corporation (DHR), notificó la venta de 2.778 acciones ordinarias de Danaher el 08/22/2025 a un precio informado de $211.058 por acción. Tras la venta, la persona informante poseía de forma indirecta y directamente 20.750,672 acciones. El Formulario 4 fue firmado mediante poder por un apoderado el 08/25/2025.

다나� 코퍼레이�(DHR) 이사� 테리 리스�(Teri List)� 2025-08-22� 다나� 보통� 2,778주를 주당 $211.058� 신고가� 매각했다� 보고했습니다. 매각 � 해당 보고인은 직접적으� � 20,750.672주를 사실� 보유하고 있었습니�. Form 4� 2025-08-25� 위임� 받은 대리인(변호사)� 서명했습니다.

Teri List, administratrice de Danaher Corporation (DHR), a déclaré la vente de 2 778 actions ordinaires Danaher le 08/22/2025 au prix indiqué de $211.058 par action. Après la cession, la personne déclarante détenait directement 20 750,672 actions à titre bénéficiaire. Le formulaire Form 4 a été signé par un mandataire muni d'une procuration le 08/25/2025.

Teri List, Direktorin der Danaher Corporation (DHR), meldete am 08/22/2025 den Verkauf von 2.778 Stammaktien von Danaher zu einem gemeldeten Kurs von $211.058 je Aktie. Nach dem Verkauf besaß die meldepflichtige Person unmittelbar wirtschaftlich 20.750,672 Aktien. Das Formblatt 4 wurde am 08/25/2025 von einem Bevollmächtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
List Teri

(Last) (First) (Middle)
2200 PENNSYLVANIA AVENUE, NW
SUITE 800W

(Street)
WASHINGTON DC 20037

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DANAHER CORP /DE/ [ DHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/22/2025 S 2,778 D $211.058 20,750.672 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/James F. O'Reilly, attorney-in-fact for Teri List 08/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What shares did Teri List sell according to the DHR Form 4?

The Form 4 reports a sale of 2,778 shares of Danaher common stock on 08/22/2025 at $211.058 per share.

How many Danaher shares does the reporting person own after the transaction?

After the reported sale, the reporting person beneficially owned 20,750.672 shares, held directly.

Was the transaction part of a 10b5-1 trading plan?

The Form 4 does not indicate that the transaction was made pursuant to a Rule 10b5-1 trading plan.

Who signed the Form 4 for Teri List?

The Form 4 was signed by James F. O'Reilly, attorney-in-fact for Teri List on 08/25/2025.

Does the Form 4 disclose any derivative transactions by the reporting person?

No. Table II for derivative securities contains no reported transactions or holdings.
Danaher Corporation

NYSE:DHR

DHR Rankings

DHR Latest News

DHR Latest SEC Filings

DHR Stock Data

142.23B
638.06M
11.05%
82.68%
1.18%
Diagnostics & Research
Industrial Instruments for Measurement, Display, and Control
United States
WASHINGTON